Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2005 Dec;22(11-12):415–417. doi: 10.1007/s10815-005-7202-6

Effect of pentoxifylline in reducing oxidative stress-induced embryotoxicity

Xiaoyan Zhang 1, Rakesh K Sharma 1,2,, Ashok Agarwal 1, Tommaso Falcone 1
PMCID: PMC3455152  PMID: 16331539

Abstract

Purpose: To 1) evaluate the embryotoxic effects of hydrogen peroxide on mouse embryo development and 2) examine if pentoxifylline can reverse hydrogen peroxide induced embryotoxicity.

Methods: Prospective in vitro study examining the effects of varying concentrations of hydrogen peroxide and pentoxifylline on the blastocyst development rate alone as well as in combination.

Results: A dose-dependent decrease in % BDR was seen with increasing concentrations of H2O2. High concentrations of hydrogen peroxide (> 60 μM) were embryotoxic. Pentoxifylline (500 μM) was able to reduce the embryotoxic effect of hydrogen peroxide. Percent blastocyst development rate increased from 44% in hydrogen peroxide alone to 85% in hydrogen peroxide and pentoxifylline coincubation.

Conclusions: Pentoxifylline may be beneficial in reducing hydrogen peroxide induced embryo damage and improve IVF outcome. Patients with endometriosis-associated infertility may benefit from the use of pentoxifylline without significantly affecting embryo development.

Keywords: Embryotoxicity, hydrogen peroxide, pentoxifylline

Full Text

The Full Text of this article is available as a PDF (62.1 KB).

Footnotes

Presented at the 60th Annual Meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October 16–20, 2004.

References

  • 1.Sharma RK, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Biol. 2004;3:177–199. doi: 10.1111/j.1447-0578.2004.00068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update. 2001;7:175–189. doi: 10.1093/humupd/7.2.175. [DOI] [PubMed] [Google Scholar]
  • 3.Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod. 2002;17:426–431. doi: 10.1093/humrep/17.2.426. [DOI] [PubMed] [Google Scholar]
  • 4.Attaran M, Pasqualotto E, Falcone T, et al. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med. 2000;45:314–320. [PubMed] [Google Scholar]
  • 5.Pasqualotto EB, Agarwal A, Sharma RK, et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril. 2004;81:973–976. doi: 10.1016/j.fertnstert.2003.11.021. [DOI] [PubMed] [Google Scholar]
  • 6.Bedaiwy MA, Goldberg JM, Falcone T, Singh M, Nelson D, Azab H, Sharma RK. Relationship between oxidative stress and embryotoxicity of hydrosalpingeal fluid. Hum Reprod. 2002;17:601–604. doi: 10.1093/humrep/17.3.601. [DOI] [PubMed] [Google Scholar]
  • 7.Szcyzepanska M, Kozlik J, Skrzypczak J, Mikolsajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril. 2003;79:1288–1293. doi: 10.1016/s0015-0282(03)00266-8. [DOI] [PubMed] [Google Scholar]
  • 8.Bedaiwy MA, Falcone T, Mohamed MS, et al. Differential growth of human embryos in vitro: Role of reactive oxygen species. Fertil Steril. 2004;82:593–600. doi: 10.1016/j.fertnstert.2004.02.121. [DOI] [PubMed] [Google Scholar]
  • 9.Yang HW, Hwang KJ, Kwon HC. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod. 1998;13:998–1002. doi: 10.1093/humrep/13.4.998. [DOI] [PubMed] [Google Scholar]
  • 10.Nasr-Esfahani MH, Aitken RJ, Johnson MH. Hydrogen peroxide levels in mouse oocytes and early cleavage stage embryos developed in vitro or in vivo. Development. 1990;109:501–507. doi: 10.1242/dev.109.2.501. [DOI] [PubMed] [Google Scholar]
  • 11.Ward A, Stephen PC. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987;34:50–97. doi: 10.2165/00003495-198734010-00003. [DOI] [PubMed] [Google Scholar]
  • 12.Steinleitner A, Lambert H, Roy S. Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: A paradigm for a novel approach to the treatment of endometriosis-associated subfertility. Fertil Steril. 1991;55:26–31. [PubMed] [Google Scholar]
  • 13.Steinleitner A, Lambert H, Suarez M. Immunomodulation in the treatment of endometriosis-associated subfertility: Use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis in a rodent model. Fertil Steril. 1991;55:975–979. [PubMed] [Google Scholar]
  • 14.Juan B, Montserrat C, Francisco F. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: A pilot randomized clinical trial. Hum Reprod. 1997;12:1046–1050. doi: 10.1093/humrep/12.9.2046. [DOI] [PubMed] [Google Scholar]
  • 15.Shanti A, Santanam N, Morales AJ, Parthasarathy S, Murphy AA. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril. 1999;71:1115–1118. doi: 10.1016/S0015-0282(99)00145-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES